TCL Archive Women’s Health Trial Committee Hears New Analysis Of Vanguard Groups, Other Data January 1, 1988
TCL Archive In Brief: US Pharmacopeia Names Advisory Panel For Hematologic And Oncological Disease May 31, 1996
TCL Archive ODAC Nixes Abraxane for Adjuvant Breast Cancer, While Genasense Falls Victim to Its Randomized Trial. September 8, 2006